GTC
NVO

Ghost Tree Capital’s Novo Nordisk NVO Stock Holding History

Ghost Tree Capital’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$13.1M Buy
+110,000
New +$14.7M 3.96% 4

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ghost Tree Capital's NVO Position: Q3 2024 in Review

Ghost Tree Capital opened a new position in Novo Nordisk (NVO) in Q3 2024: 110,000 shares worth $13.1M. The stake represents 3.96% of the portfolio and ranks #4 among its holdings.

1,784 funds tracked by Wall St. Rank hold NVO as of Q3 2024.

  • Ghost Tree Capital held 110,000 shares of Novo Nordisk worth $13.1M as of Q3 2024.
  • Novo Nordisk was a new Ghost Tree Capital position in Q3 2024.
  • Novo Nordisk made up 3.96% of Ghost Tree Capital's portfolio in Q3 2024, its #4 holding.
  • 1,784 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2024.

Based on Ghost Tree Capital's 13F filing for Q3 2024, filed 14 Nov 2024.